Evidence map›Paper›PMID 35663283›Full record

ArticleCurrent research in pharmacology and drug discovery2022

Three-dimensional spheroids of choroid-retinal vascular endothelial cells as an

Manish Gore, Ankit Tiwari, Devashree Jahagirdar, Angayarkanni Narayanasamy, Ratnesh Jain, Prajakta Dandekar

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current research in pharmacology and drug discovery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Nanomedicine in Ophthalmology: From Bench to Bedside.Journal of clinical medicine · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Manish GoreDepartment of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, 400 019, India.
Ankit TiwariDepartment of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, 400 019, India.
Devashree JahagirdarDepartment of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, 400 019, India.
Angayarkanni NarayanasamyDepartment of Biochemistry and Cell Biology, Vision Research Foundation, Sankara Nethralaya, Chennai, 600 006, India.
Ratnesh JainDepartment of Chemical Engineering, Institute of Chemical Technology, Mumbai, 400 019, India.
Prajakta DandekarDepartment of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, 400 019, India.
Institute of Chemical Technology · INSankara Nethralaya · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic retinopathy (DR) is a primary microvascular complication of

Indexed as

AngiogenesisChoroid-retinal vascular endothelial cellsDiabetic retinopathyIn-vitroSpheroidsThree-dimensional

Identifiers

PMID35663283
PMCPMC9157473
OpenAlexW4281253736

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.